,p-pC-MG vs p-dC-MG in porcine with VNS,p-pC-MG vs p-dC-MG in porcine without VNS
Gap junctions,14.41892088,-4.943095149
Pro-inflammatory signaling ,35.01886183,-10.50168945
Anti-inflammatory signaling ,45.62653381,-10.20411998
Human orthologous risk genes for intestinal and extra-intestinal diseases,6.980998428,17.52578374
Smooth muscle contraction,-20.52072795,-1.408935393
Cannabinoid receptor signaling,41.46220885,4.200659451
Chemokine signaling pathway,43.25448307,-7.626154281
Dopaminergic Neurogenesis,4.191046633,-2.600349046
GABA receptor Signaling,-10.20520715,4.269217724
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",-10.80112744,0
Neurotransmitter receptors and postsynaptic signal transmission,2.815742588,3.575118363
Neurotransmitter release cycle,12.86497427,25.92713488
Neurotransmitter uptake and metabolism In glial cells,6.912535903,0
Nicotine Activity on Dopaminergic Neurons,38.18207947,6.349751965
NO/cGMP/PKG mediated Neuroprotection,21.72521634,-1.408935393
Oncostatin M Signaling Pathway,44.36682269,-6.695536828
Phosphodiesterases in neuronal function,49.47676524,-1.419075024
PI3K-Akt Signaling Pathway,-5.284046727,-3.568636236
Synaptic Vesicle Pathway,6.928604415,26.81376366
TGF-beta Receptor Signaling,22.86650945,-18.02701884
,,
,,
,p-pC-MG vs p-pC-ISG in porcine with VNS,p-pC-MG vs p-pC-ISG in porcine without VNS
Gap junctions,15.48552158,38.58718733
Pro-inflammatory signaling ,44.76355898,16.59633798
Anti-inflammatory signaling ,38.94173535,102.6252517
Human orthologous risk genes for intestinal and extra-intestinal diseases,25.90916527,49.91891812
Smooth muscle contraction,42.61500252,87.23374797
Acetylcholine binding and downstream events,3.083283905,-10.23433145
Cannabinoid receptor signaling,19.3319957,13.96327719
Chemokine signaling pathway,63.61063684,84.85398218
Cytokines and Inflammatory Response,22.32645501,52.11909024
Effects of Nitric Oxide (NOS1),10.21584085,11.49894074
GABA receptor Signaling,10.29100032,7.955494079
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",11.02001827,62.22307039
Metabolism of nitric oxide: NOS3 activation and regulation,6.963688559,4.68918405
Neurotransmitter clearance,13.57578844,14.94309515
Neurotransmitter release cycle,7.102998936,-34.98127751
Nicotine Activity on Dopaminergic Neurons,49.89226351,42.38060445
NO/cGMP/PKG mediated Neuroprotection,27.72637995,-0.932043927
Oncostatin M Signaling Pathway,65.49003457,94.39901633
Phosphodiesterases in neuronal function,55.32848079,60.63777554
PI3K-Akt Signaling Pathway,7.629352349,5.764845784
Synaptic Vesicle Pathway,16.80415927,-21.07530191
TGF-beta Receptor Signaling,31.94600261,115.2868725
COVID-19 Adverse Outcome Pathway,-6.791300992,-15.23957752